Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin

Katharina Medek* (First author), Sylvia Selhofer (Co-author), Buchner Matthias, Ulrich Mrowietz, Martin Laimer (Last author)

*Corresponding author for this work

Research output: Contribution to journalCase reportpeer-review

7 Citations (Web of Science)

Abstract

Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disease that occurs with phenotypic variability in adults of all ages as well as in children. Data on the treatment of PRP is limited. Here, we report a 5-year-old girl with widespread skin involvement and prominent palmoplantar hyperkeratosis who was initially treated for psoriasis. After reevaluation, a diagnosis of PRP was made, and the patient had an excellent therapeutic response to ustekinumab and acitretin.
Original languageEnglish
Pages (from-to)659-661
JournalPEDIATRIC DERMATOLOGY
Volume39
Issue number4
DOIs
Publication statusPublished - 20 Jul 2022

Cite this